-5COVID-19,:,,,

Feng-Cai Zhu1, Yu-Hua Li2, Xu-Hua Guan3

  • 1NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.

PubMed
概括

这一第一阶段试验发现腺病毒类型-5 (Ad5) 载体的COVID-19疫苗是安全和免疫的. Ad5 COVID-19 疫苗显示出可容忍的安全性,并诱导显著的抗体和T细胞反应.